APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Prothrombin Complex Concentrate

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Human Prothrombin Complex Concentrate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025191 pages

Choose your research edition.

Industry ResearchHuman Prothrombin Complex Concentrate Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Prothrombin Complex Concentrate Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Human Prothrombin Complex Concentrate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Prothrombin Complex Concentrate Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Prothrombin Complex Concentrate Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Human Prothrombin Complex Concentrate market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Human Prothrombin Complex Concentrate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Human Prothrombin Complex Concentrate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Human Prothrombin Complex Concentrate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Human Prothrombin Complex Concentrate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Human Prothrombin Complex Concentrate include Takeda, Weiguang Biology, Thailand Bio, Shanghai Emerging Pharmaceuticals, Shanghai RAAS, Green Cross (China) Biological Products Co., Ltd., Jiangxi Boya Biopharmaceutical Co., Ltd., Hualan Bio and Guangdong Shuanglin Biopharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Human Prothrombin Complex Concentrate market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Human Prothrombin Complex Concentrate and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Human Prothrombin Complex Concentrate sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Human Prothrombin Complex Concentrate market size, projected growth trends, production technologies, key applications, and end-use industries.

Human Prothrombin Complex Concentrate Segment by Company

Takeda

Weiguang Biology

Thailand Bio

Shanghai Emerging Pharmaceuticals

Shanghai RAAS

Green Cross (China) Biological Products Co., Ltd.

Jiangxi Boya Biopharmaceutical Co., Ltd.

Hualan Bio

Guangdong Shuanglin Biopharmaceutical Co., Ltd.

Beijing Tiantan Biological Products Co., Ltd.

Beijing Bohui Innovative Biotechnology Group Co., Ltd.

Octapharma

Grifols

CSL

Biotest

Human Prothrombin Complex Concentrate Segment by Type

500 IU

1000 IU

Human Prothrombin Complex Concentrate Segment by Application

Hemophilia B

Vitamin K Deficiency

Other

Human Prothrombin Complex Concentrate Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Prothrombin Complex Concentrate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Prothrombin Complex Concentrate and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Prothrombin Complex Concentrate.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Human Prothrombin Complex Concentrate market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Human Prothrombin Complex Concentrate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Human Prothrombin Complex Concentrate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Human Prothrombin Complex Concentrate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Human Prothrombin Complex Concentrate Industry Trends Table 2. Human Prothrombin Complex Concentrate Industry Drivers Table 3. Human Prothrombin Complex Concentrate Industry Opportunities and Challenges Table 4. Human Prothrombin Complex Concentrate Industry Restraints Table 5. Global Human Prothrombin Complex Concentrate Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Human Prothrombin Complex Concentrate Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Human Prothrombin Complex Concentrate Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Human Prothrombin Complex Concentrate Sales Market Share by Manufacturers Table 9. Global Human Prothrombin Complex Concentrate Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Human Prothrombin Complex Concentrate Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Human Prothrombin Complex Concentrate Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Human Prothrombin Complex Concentrate Manufacturers, Product Type & Application Table 13. Global Human Prothrombin Complex Concentrate Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Human Prothrombin Complex Concentrate by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 500 IU Table 17. Major Manufacturers of 1000 IU Table 18. Global Human Prothrombin Complex Concentrate Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Human Prothrombin Complex Concentrate Sales by Type (2021-2026) & (k units) Table 20. Global Human Prothrombin Complex Concentrate Sales by Type (2027-2032) & (k units) Table 21. Global Human Prothrombin Complex Concentrate Sales Market Share by Type (2021-2026) Table 22. Global Human Prothrombin Complex Concentrate Sales Market Share by Type (2027-2032) Table 23. Global Human Prothrombin Complex Concentrate Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Human Prothrombin Complex Concentrate Revenue by Type (2021-2026) & (k units) Table 25. Global Human Prothrombin Complex Concentrate Revenue by Type (2027-2032) & (k units) Table 26. Global Human Prothrombin Complex Concentrate Revenue Market Share by Type (2021-2026) Table 27. Global Human Prothrombin Complex Concentrate Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hemophilia B Table 29. Major Manufacturers of Vitamin K Deficiency Table 30. Major Manufacturers of Other Table 31. Global Human Prothrombin Complex Concentrate Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Human Prothrombin Complex Concentrate Sales by Application (2021-2026) & (k units) Table 33. Global Human Prothrombin Complex Concentrate Sales by Application (2027-2032) & (k units) Table 34. Global Human Prothrombin Complex Concentrate Sales Market Share by Application (2021-2026) Table 35. Global Human Prothrombin Complex Concentrate Sales Market Share by Application (2027-2032) Table 36. Global Human Prothrombin Complex Concentrate Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Human Prothrombin Complex Concentrate Revenue by Application (2021-2026) & (k units) Table 38. Global Human Prothrombin Complex Concentrate Revenue by Application (2027-2032) & (k units) Table 39. Global Human Prothrombin Complex Concentrate Revenue Market Share by Application (2021-2026) Table 40. Global Human Prothrombin Complex Concentrate Revenue Market Share by Application (2027-2032) Table 41. Global Human Prothrombin Complex Concentrate Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Human Prothrombin Complex Concentrate Sales by Region (2021-2026) & (k units) Table 43. Global Human Prothrombin Complex Concentrate Sales Market Share by Region (2021-2026) Table 44. Global Human Prothrombin Complex Concentrate Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global Human Prothrombin Complex Concentrate Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Human Prothrombin Complex Concentrate Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America Human Prothrombin Complex Concentrate Sales by Country (2021-2026) & (k units) Table 48. North America Human Prothrombin Complex Concentrate Sales by Country (2027-2032) & (k units) Table 49. Europe Human Prothrombin Complex Concentrate Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe Human Prothrombin Complex Concentrate Sales by Country (2021-2026) & (k units) Table 51. Europe Human Prothrombin Complex Concentrate Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific Human Prothrombin Complex Concentrate Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific Human Prothrombin Complex Concentrate Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific Human Prothrombin Complex Concentrate Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa Human Prothrombin Complex Concentrate Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa Human Prothrombin Complex Concentrate Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa Human Prothrombin Complex Concentrate Sales by Country (2027-2032) & (k units) Table 58. Global Human Prothrombin Complex Concentrate Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Human Prothrombin Complex Concentrate Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Human Prothrombin Complex Concentrate Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Human Prothrombin Complex Concentrate Revenue Market Share by Region (2021-2026) Table 62. Global Human Prothrombin Complex Concentrate Revenue Market Share by Region (2027-2032) Table 63. Takeda Company Information Table 64. Takeda Business Overview Table 65. Takeda Human Prothrombin Complex Concentrate Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Takeda Human Prothrombin Complex Concentrate Product Portfolio Table 67. Takeda Recent Development Table 68. Weiguang Biology Company Information Table 69. Weiguang Biology Business Overview Table 70. Weiguang Biology Human Prothrombin Complex Concentrate Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Weiguang Biology Human Prothrombin Complex Concentrate Product Portfolio Table 72. Weiguang Biology Recent Development Table 73. Thailand Bio Company Information Table 74. Thailand Bio Business Overview Table 75. Thailand Bio Human Prothrombin Complex Concentrate Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Thailand Bio Human Prothrombin Complex Concentrate Product Portfolio Table 77. Thailand Bio Recent Development Table 78. Shanghai Emerging Pharmaceuticals Company Information Table 79. Shanghai Emerging Pharmaceuticals Business Overview Table 80. Shanghai Emerging Pharmaceuticals Human Prothrombin Complex Concentrate Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Shanghai Emerging Pharmaceuticals Human Prothrombin Complex Concentrate Product Portfolio Table 82. Shanghai Emerging Pharmaceuticals Recent Development Table 83. Shanghai RAAS Company Information Table 84. Shanghai RAAS Business Overview Table 85. Shanghai RAAS Human Prothrombin Complex Concentrate Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Shanghai RAAS Human Prothrombin Complex Concentrate Product Portfolio Table 87. Shanghai RAAS Recent Development Table 88. Green Cross (China) Biological Products Co., Ltd. Company Information Table 89. Green Cross (China) Biological Products Co., Ltd. Business Overview Table 90. Green Cross (China) Biological Products Co., Ltd. Human Prothrombin Complex Concentrate Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Green Cross (China) Biological Products Co., Ltd. Human Prothrombin Complex Concentrate Product Portfolio Table 92. Green Cross (China) Biological Products Co., Ltd. Recent Development Table 93. Jiangxi Boya Biopharmaceutical Co., Ltd. Company Information Table 94. Jiangxi Boya Biopharmaceutical Co., Ltd. Business Overview Table 95. Jiangxi Boya Biopharmaceutical Co., Ltd. Human Prothrombin Complex Concentrate Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Jiangxi Boya Biopharmaceutical Co., Ltd. Human Prothrombin Complex Concentrate Product Portfolio Table 97. Jiangxi Boya Biopharmaceutical Co., Ltd. Recent Development Table 98. Hualan Bio Company Information Table 99. Hualan Bio Business Overview Table 100. Hualan Bio Human Prothrombin Complex Concentrate Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Hualan Bio Human Prothrombin Complex Concentrate Product Portfolio Table 102. Hualan Bio Recent Development Table 103. Guangdong Shuanglin Biopharmaceutical Co., Ltd. Company Information Table 104. Guangdong Shuanglin Biopharmaceutical Co., Ltd. Business Overview Table 105. Guangdong Shuanglin Biopharmaceutical Co., Ltd. Human Prothrombin Complex Concentrate Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Guangdong Shuanglin Biopharmaceutical Co., Ltd. Human Prothrombin Complex Concentrate Product Portfolio Table 107. Guangdong Shuanglin Biopharmaceutical Co., Ltd. Recent Development Table 108. Beijing Tiantan Biological Products Co., Ltd. Company Information Table 109. Beijing Tiantan Biological Products Co., Ltd. Business Overview Table 110. Beijing Tiantan Biological Products Co., Ltd. Human Prothrombin Complex Concentrate Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Beijing Tiantan Biological Products Co., Ltd. Human Prothrombin Complex Concentrate Product Portfolio Table 112. Beijing Tiantan Biological Products Co., Ltd. Recent Development Table 113. Beijing Bohui Innovative Biotechnology Group Co., Ltd. Company Information Table 114. Beijing Bohui Innovative Biotechnology Group Co., Ltd. Business Overview Table 115. Beijing Bohui Innovative Biotechnology Group Co., Ltd. Human Prothrombin Complex Concentrate Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Beijing Bohui Innovative Biotechnology Group Co., Ltd. Human Prothrombin Complex Concentrate Product Portfolio Table 117. Beijing Bohui Innovative Biotechnology Group Co., Ltd. Recent Development Table 118. Octapharma Company Information Table 119. Octapharma Business Overview Table 120. Octapharma Human Prothrombin Complex Concentrate Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Octapharma Human Prothrombin Complex Concentrate Product Portfolio Table 122. Octapharma Recent Development Table 123. Grifols Company Information Table 124. Grifols Business Overview Table 125. Grifols Human Prothrombin Complex Concentrate Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Grifols Human Prothrombin Complex Concentrate Product Portfolio Table 127. Grifols Recent Development Table 128. CSL Company Information Table 129. CSL Business Overview Table 130. CSL Human Prothrombin Complex Concentrate Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. CSL Human Prothrombin Complex Concentrate Product Portfolio Table 132. CSL Recent Development Table 133. Biotest Company Information Table 134. Biotest Business Overview Table 135. Biotest Human Prothrombin Complex Concentrate Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Biotest Human Prothrombin Complex Concentrate Product Portfolio Table 137. Biotest Recent Development Table 138. Key Raw Materials Table 139. Raw Materials Key Suppliers Table 140. Human Prothrombin Complex Concentrate Distributors List Table 141. Human Prothrombin Complex Concentrate Customers List Table 142. Research Programs/Design for This Report Table 143. Authors List of This Report Table 144. Secondary Sources Table 145. Primary Sources List of Figures Figure 1. Human Prothrombin Complex Concentrate Product Image Figure 2. Global Human Prothrombin Complex Concentrate Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Prothrombin Complex Concentrate Market Size (2021-2032) & (US$ Million) Figure 4. Global Human Prothrombin Complex Concentrate Sales (2021-2032) & (k units) Figure 5. Global Human Prothrombin Complex Concentrate Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Human Prothrombin Complex Concentrate Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 500 IU Image Figure 9. 1000 IU Image Figure 10. Global Human Prothrombin Complex Concentrate Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Human Prothrombin Complex Concentrate Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Human Prothrombin Complex Concentrate Sales Market Share by Type (2021-2032) Figure 13. Global Human Prothrombin Complex Concentrate Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Human Prothrombin Complex Concentrate Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Human Prothrombin Complex Concentrate Revenue Market Share by Type (2021-2032) Figure 16. Hemophilia B Image Figure 17. Vitamin K Deficiency Image Figure 18. Other Image Figure 19. Global Human Prothrombin Complex Concentrate Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Human Prothrombin Complex Concentrate Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Human Prothrombin Complex Concentrate Sales Market Share by Application (2021-2032) Figure 22. Global Human Prothrombin Complex Concentrate Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Human Prothrombin Complex Concentrate Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Human Prothrombin Complex Concentrate Revenue Market Share by Application (2021-2032) Figure 25. North America Human Prothrombin Complex Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America Human Prothrombin Complex Concentrate Sales Market Share by Country (2021-2032) Figure 27. U.S. Human Prothrombin Complex Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada Human Prothrombin Complex Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico Human Prothrombin Complex Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Human Prothrombin Complex Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Human Prothrombin Complex Concentrate Sales Market Share by Country (2021-2032) Figure 32. Germany Human Prothrombin Complex Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 33. France Human Prothrombin Complex Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. Human Prothrombin Complex Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy Human Prothrombin Complex Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands Human Prothrombin Complex Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Human Prothrombin Complex Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Human Prothrombin Complex Concentrate Sales Market Share by Country (2021-2032) Figure 39. China Human Prothrombin Complex Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan Human Prothrombin Complex Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea Human Prothrombin Complex Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia Human Prothrombin Complex Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 43. India Human Prothrombin Complex Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia Human Prothrombin Complex Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Human Prothrombin Complex Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Human Prothrombin Complex Concentrate Sales Market Share by Country (2021-2032) Figure 47. Brazil Human Prothrombin Complex Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa Human Prothrombin Complex Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia Human Prothrombin Complex Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey Human Prothrombin Complex Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina Human Prothrombin Complex Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE Human Prothrombin Complex Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt Human Prothrombin Complex Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile Human Prothrombin Complex Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global Human Prothrombin Complex Concentrate Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Human Prothrombin Complex Concentrate Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Human Prothrombin Complex Concentrate Revenue (2021-2032) & (US$ Million) Figure 58. North America Human Prothrombin Complex Concentrate Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Human Prothrombin Complex Concentrate Revenue (2021-2032) & (US$ Million) Figure 60. Europe Human Prothrombin Complex Concentrate Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Human Prothrombin Complex Concentrate Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Human Prothrombin Complex Concentrate Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Human Prothrombin Complex Concentrate Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Human Prothrombin Complex Concentrate Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Human Prothrombin Complex Concentrate Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Human Prothrombin Complex Concentrate Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 500 IU
  • 1000 IU
Applications
  • Hemophilia B
  • Vitamin K Deficiency
  • Other
Companies covered
  • Takeda
  • Weiguang Biology
  • Thailand Bio
  • Shanghai Emerging Pharmaceuticals
  • Shanghai RAAS
  • Green Cross (China) Biological Products Co., Ltd.
  • Jiangxi Boya Biopharmaceutical Co., Ltd.
  • Hualan Bio
  • Guangdong Shuanglin Biopharmaceutical Co., Ltd.
  • Beijing Tiantan Biological Products Co., Ltd.
  • Beijing Bohui Innovative Biotechnology Group Co., Ltd.
  • Octapharma
  • Grifols
  • CSL
  • Biotest

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Human Prothrombin Complex Concentrate Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Human Prothrombin Complex Concentrate Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Human Prothrombin Complex Concentrate Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Human Prothrombin Complex Concentrate Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Human Prothrombin Complex Concentrate Market Dynamics
  1. 2.1 Human Prothrombin Complex Concentrate Industry Trends
  2. 2.2 Human Prothrombin Complex Concentrate Industry Drivers
  3. 2.3 Human Prothrombin Complex Concentrate Industry Opportunities and Challenges
  4. 2.4 Human Prothrombin Complex Concentrate Industry Restraints
3 Human Prothrombin Complex Concentrate Market by Manufacturers
  1. 3.1 Global Human Prothrombin Complex Concentrate Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Human Prothrombin Complex Concentrate Sales by Manufacturers (2021-2026)
  3. 3.3 Global Human Prothrombin Complex Concentrate Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Human Prothrombin Complex Concentrate Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Human Prothrombin Complex Concentrate Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Human Prothrombin Complex Concentrate Manufacturers, Product Type & Application
  7. 3.7 Global Human Prothrombin Complex Concentrate Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Human Prothrombin Complex Concentrate Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Human Prothrombin Complex Concentrate Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Human Prothrombin Complex Concentrate Tier 1, Tier 2, and Tier 3
4 Human Prothrombin Complex Concentrate Market by Type
  1. 4.1 Human Prothrombin Complex Concentrate Type Introduction
  2. 4.1.1 500 IU
  3. 4.1.2 1000 IU
  4. 4.2 Global Human Prothrombin Complex Concentrate Sales by Type
  5. 4.2.1 Global Human Prothrombin Complex Concentrate Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Human Prothrombin Complex Concentrate Sales by Type (2021-2032)
  7. 4.2.3 Global Human Prothrombin Complex Concentrate Sales Market Share by Type (2021-2032)
  8. 4.3 Global Human Prothrombin Complex Concentrate Revenue by Type
  9. 4.3.1 Global Human Prothrombin Complex Concentrate Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Human Prothrombin Complex Concentrate Revenue by Type (2021-2032)
  11. 4.3.3 Global Human Prothrombin Complex Concentrate Revenue Market Share by Type (2021-2032)
5 Human Prothrombin Complex Concentrate Market by Application
  1. 5.1 Human Prothrombin Complex Concentrate Application Introduction
  2. 5.1.1 Hemophilia B
  3. 5.1.2 Vitamin K Deficiency
  4. 5.1.3 Other
  5. 5.2 Global Human Prothrombin Complex Concentrate Sales by Application
  6. 5.2.1 Global Human Prothrombin Complex Concentrate Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Human Prothrombin Complex Concentrate Sales by Application (2021-2032)
  8. 5.2.3 Global Human Prothrombin Complex Concentrate Sales Market Share by Application (2021-2032)
  9. 5.3 Global Human Prothrombin Complex Concentrate Revenue by Application
  10. 5.3.1 Global Human Prothrombin Complex Concentrate Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Human Prothrombin Complex Concentrate Revenue by Application (2021-2032)
  12. 5.3.3 Global Human Prothrombin Complex Concentrate Revenue Market Share by Application (2021-2032)
6 Global Human Prothrombin Complex Concentrate Sales by Region
  1. 6.1 Global Human Prothrombin Complex Concentrate Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Human Prothrombin Complex Concentrate Sales by Region (2021-2032)
  3. 6.2.1 Global Human Prothrombin Complex Concentrate Sales by Region (2021-2026)
  4. 6.2.2 Global Human Prothrombin Complex Concentrate Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Human Prothrombin Complex Concentrate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Human Prothrombin Complex Concentrate Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Human Prothrombin Complex Concentrate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Human Prothrombin Complex Concentrate Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Human Prothrombin Complex Concentrate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Human Prothrombin Complex Concentrate Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Human Prothrombin Complex Concentrate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Human Prothrombin Complex Concentrate Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Human Prothrombin Complex Concentrate Revenue by Region
  1. 7.1 Global Human Prothrombin Complex Concentrate Revenue by Region
  2. 7.1.1 Global Human Prothrombin Complex Concentrate Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Human Prothrombin Complex Concentrate Revenue by Region (2021-2026)
  4. 7.1.3 Global Human Prothrombin Complex Concentrate Revenue by Region (2027-2032)
  5. 7.1.4 Global Human Prothrombin Complex Concentrate Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Human Prothrombin Complex Concentrate Revenue (2021-2032)
  8. 7.2.2 North America Human Prothrombin Complex Concentrate Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Human Prothrombin Complex Concentrate Revenue (2021-2032)
  11. 7.3.2 Europe Human Prothrombin Complex Concentrate Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Human Prothrombin Complex Concentrate Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Human Prothrombin Complex Concentrate Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Human Prothrombin Complex Concentrate Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Human Prothrombin Complex Concentrate Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda
  2. 8.1.1 Takeda Company Information
  3. 8.1.2 Takeda Business Overview
  4. 8.1.3 Takeda Human Prothrombin Complex Concentrate Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Human Prothrombin Complex Concentrate Product Portfolio
  6. 8.1.5 Takeda Recent Developments
  7. 8.2 Weiguang Biology
  8. 8.2.1 Weiguang Biology Company Information
  9. 8.2.2 Weiguang Biology Business Overview
  10. 8.2.3 Weiguang Biology Human Prothrombin Complex Concentrate Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Weiguang Biology Human Prothrombin Complex Concentrate Product Portfolio
  12. 8.2.5 Weiguang Biology Recent Developments
  13. 8.3 Thailand Bio
  14. 8.3.1 Thailand Bio Company Information
  15. 8.3.2 Thailand Bio Business Overview
  16. 8.3.3 Thailand Bio Human Prothrombin Complex Concentrate Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Thailand Bio Human Prothrombin Complex Concentrate Product Portfolio
  18. 8.3.5 Thailand Bio Recent Developments
  19. 8.4 Shanghai Emerging Pharmaceuticals
  20. 8.4.1 Shanghai Emerging Pharmaceuticals Company Information
  21. 8.4.2 Shanghai Emerging Pharmaceuticals Business Overview
  22. 8.4.3 Shanghai Emerging Pharmaceuticals Human Prothrombin Complex Concentrate Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Shanghai Emerging Pharmaceuticals Human Prothrombin Complex Concentrate Product Portfolio
  24. 8.4.5 Shanghai Emerging Pharmaceuticals Recent Developments
  25. 8.5 Shanghai RAAS
  26. 8.5.1 Shanghai RAAS Company Information
  27. 8.5.2 Shanghai RAAS Business Overview
  28. 8.5.3 Shanghai RAAS Human Prothrombin Complex Concentrate Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Shanghai RAAS Human Prothrombin Complex Concentrate Product Portfolio
  30. 8.5.5 Shanghai RAAS Recent Developments
  31. 8.6 Green Cross (China) Biological Products Co., Ltd.
  32. 8.6.1 Green Cross (China) Biological Products Co., Ltd. Company Information
  33. 8.6.2 Green Cross (China) Biological Products Co., Ltd. Business Overview
  34. 8.6.3 Green Cross (China) Biological Products Co., Ltd. Human Prothrombin Complex Concentrate Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Green Cross (China) Biological Products Co., Ltd. Human Prothrombin Complex Concentrate Product Portfolio
  36. 8.6.5 Green Cross (China) Biological Products Co., Ltd. Recent Developments
  37. 8.7 Jiangxi Boya Biopharmaceutical Co., Ltd.
  38. 8.7.1 Jiangxi Boya Biopharmaceutical Co., Ltd. Company Information
  39. 8.7.2 Jiangxi Boya Biopharmaceutical Co., Ltd. Business Overview
  40. 8.7.3 Jiangxi Boya Biopharmaceutical Co., Ltd. Human Prothrombin Complex Concentrate Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Jiangxi Boya Biopharmaceutical Co., Ltd. Human Prothrombin Complex Concentrate Product Portfolio
  42. 8.7.5 Jiangxi Boya Biopharmaceutical Co., Ltd. Recent Developments
  43. 8.8 Hualan Bio
  44. 8.8.1 Hualan Bio Company Information
  45. 8.8.2 Hualan Bio Business Overview
  46. 8.8.3 Hualan Bio Human Prothrombin Complex Concentrate Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Hualan Bio Human Prothrombin Complex Concentrate Product Portfolio
  48. 8.8.5 Hualan Bio Recent Developments
  49. 8.9 Guangdong Shuanglin Biopharmaceutical Co., Ltd.
  50. 8.9.1 Guangdong Shuanglin Biopharmaceutical Co., Ltd. Company Information
  51. 8.9.2 Guangdong Shuanglin Biopharmaceutical Co., Ltd. Business Overview
  52. 8.9.3 Guangdong Shuanglin Biopharmaceutical Co., Ltd. Human Prothrombin Complex Concentrate Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Guangdong Shuanglin Biopharmaceutical Co., Ltd. Human Prothrombin Complex Concentrate Product Portfolio
  54. 8.9.5 Guangdong Shuanglin Biopharmaceutical Co., Ltd. Recent Developments
  55. 8.10 Beijing Tiantan Biological Products Co., Ltd.
  56. 8.10.1 Beijing Tiantan Biological Products Co., Ltd. Company Information
  57. 8.10.2 Beijing Tiantan Biological Products Co., Ltd. Business Overview
  58. 8.10.3 Beijing Tiantan Biological Products Co., Ltd. Human Prothrombin Complex Concentrate Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Beijing Tiantan Biological Products Co., Ltd. Human Prothrombin Complex Concentrate Product Portfolio
  60. 8.10.5 Beijing Tiantan Biological Products Co., Ltd. Recent Developments
  61. 8.11 Beijing Bohui Innovative Biotechnology Group Co., Ltd.
  62. 8.11.1 Beijing Bohui Innovative Biotechnology Group Co., Ltd. Company Information
  63. 8.11.2 Beijing Bohui Innovative Biotechnology Group Co., Ltd. Business Overview
  64. 8.11.3 Beijing Bohui Innovative Biotechnology Group Co., Ltd. Human Prothrombin Complex Concentrate Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Beijing Bohui Innovative Biotechnology Group Co., Ltd. Human Prothrombin Complex Concentrate Product Portfolio
  66. 8.11.5 Beijing Bohui Innovative Biotechnology Group Co., Ltd. Recent Developments
  67. 8.12 Octapharma
  68. 8.12.1 Octapharma Company Information
  69. 8.12.2 Octapharma Business Overview
  70. 8.12.3 Octapharma Human Prothrombin Complex Concentrate Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Octapharma Human Prothrombin Complex Concentrate Product Portfolio
  72. 8.12.5 Octapharma Recent Developments
  73. 8.13 Grifols
  74. 8.13.1 Grifols Company Information
  75. 8.13.2 Grifols Business Overview
  76. 8.13.3 Grifols Human Prothrombin Complex Concentrate Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Grifols Human Prothrombin Complex Concentrate Product Portfolio
  78. 8.13.5 Grifols Recent Developments
  79. 8.14 CSL
  80. 8.14.1 CSL Company Information
  81. 8.14.2 CSL Business Overview
  82. 8.14.3 CSL Human Prothrombin Complex Concentrate Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 CSL Human Prothrombin Complex Concentrate Product Portfolio
  84. 8.14.5 CSL Recent Developments
  85. 8.15 Biotest
  86. 8.15.1 Biotest Company Information
  87. 8.15.2 Biotest Business Overview
  88. 8.15.3 Biotest Human Prothrombin Complex Concentrate Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Biotest Human Prothrombin Complex Concentrate Product Portfolio
  90. 8.15.5 Biotest Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Human Prothrombin Complex Concentrate Value Chain Analysis
  2. 9.1.1 Human Prothrombin Complex Concentrate Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Human Prothrombin Complex Concentrate Production Mode & Process
  6. 9.2 Human Prothrombin Complex Concentrate Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Human Prothrombin Complex Concentrate Distributors
  9. 9.2.3 Human Prothrombin Complex Concentrate Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst